BIOPOOL INTERNATIONAL INC
10QSB, 1996-04-30
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: COMPOSITE DEFERRED VARIABLE ACCT OF EMPIRE LIFE INSURANCE CO, 485BPOS, 1996-04-30
Next: PIONEER AMERICA INCOME TRUST, 497J, 1996-04-30



<PAGE>
______________________________________________________________________
______________________________________________________________________
                                       
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549


                                 FORM 10-QSB
                                       
           /X/  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       SECURITIES EXCHANGE ACT OF 1934

          / /  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                     THE SECURITIES EXCHANGE ACT OF 1934

                     For the quarter ended March 31, 1996
          _________________________________________________________

                        COMMISSION FILE NUMBER 0-17714
          _________________________________________________________

                         BIOPOOL INTERNATIONAL, INC.
            (Exact name of Registrant as specified in its charter)

            DELAWARE                                  58-1729436
(State or other jurisdiction of                    (I.R.S. Employer
 incorporation or organization)                   Identification No.)


       6025 Nicolle Street                               93003
       Ventura, California                            (Zip Code)
(Address of principal executive offices)

Registrant's telephone number including area code:  (805) 654-0643

_________________________________________________________________________

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the proceeding 12 months (or for such shorter period
that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

                            YES  [X]      NO  [ ]

Indicate the number of shares outstanding of each of the issuer's classes
of Common Stock, as of the latest practicable date.

Outstanding at March 31, 1996, Common Stock, $.01 par value per share,
7,966,139 shares.

_________________________________________________________________________
________________________________________________________________________



<PAGE>
                         BIOPOOL INTERNATIONAL, INC.

                              TABLE OF CONTENTS

                                                               Page
PART I. FINANCIAL INFORMATION

     Item 1 - Financial Statements (Unaudited)

              Consolidated Balance Sheets as of March 31,       
              1996 and December 31, 1995                        3

              Consolidated Statements of Income for the
              Three-Month Periods Ending March 31, 1996
              and 1995                                          5

              Consolidated Statements of Cash Flows for 
              the Three-Month Periods Ending March 31, 1996
              and 1995                                          6

              Notes to Consolidated Financial Statements        7

     Item 2 - Management's Discussion and Analysis or 
              Plan of Operation                                 9

PART II.     OTHER INFORMATION

     Item 1 - Legal Proceedings                                 10

     Item 2 - Changes in Securities 
              Not Applicable

     Item 3 - Defaults upon Senior Securities
              Not Applicable

     Item 4 - Submission of Matters to a Vote of Security
              Holders
              Not Applicable

     Item 5 - Other Information
              Not Applicable

     Item 6 - a)  No Exhibits
     
              b)  The Company did not file any reports on
                  Form 8-K during the three months ended
                  March 31, 1996.


SIGNATURES                                                      11




                                      2


<PAGE>
<TABLE>
                         BIOPOOL INTERNATIONAL, INC.

                         CONSOLIDATED BALANCE SHEETS
<CAPTION>
                                         March 31,      December 31,
                                            1996            1995    
                                        (Unaudited)
_______________________________________________________________________
<S>                                   <C>             <C>
ASSETS

CURRENT ASSETS
  Cash and cash equivalents           $  1,284,311    $   1,282,527 
  Accounts receivable, net of
    allowance for doubtful
    accounts of $12,856 and
    $10,477, in 1996 and 1995,
    respectively                         1,360,702        1,153,608 
  Inventories                            1,887,175        1,841,910 
  Prepaid expenses and other
    current assets                         365,204          414,880 
  Refundable income taxes                   31,392           61,820 
  Deferred income taxes                     29,838               -- 
_______________________________________________________________________

TOTAL CURRENT ASSETS                     4,958,622        4,754,745 
_______________________________________________________________________

PROPERTY AND EQUIPMENT                   3,595,254        3,485,030 
  Less accumulated depreciation
    and amortization                    (1,808,372)      (1,713,952)
_______________________________________________________________________

PROPERTY AND EQUIPMENT, NET              1,786,882        1,771,078 
_______________________________________________________________________

OTHER ASSETS
  Patent application costs, net            149,247          150,555 
  Excess of cost over net assets
    of acquired companies, net             656,821          670,586 
  Other assets                              67,996           88,777 
_______________________________________________________________________

TOTAL OTHER ASSETS                         874,064          909,918 
_______________________________________________________________________

TOTAL ASSETS                          $  7,619,568    $   7,435,741 
_______________________________________________________________________
</TABLE>

See accompanying notes to consolidated financial statements.



                                      3

<PAGE>
<TABLE>
                         BIOPOOL INTERNATIONAL, INC.

                         CONSOLIDATED BALANCE SHEETS
                                 (continued)
<CAPTION>
                                         March 31,       December 31,
                                           1996              1995    
                                        (Unaudited) 
_______________________________________________________________________
<S>                                   <C>             <C>
LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES
  Bank borrowings                     $     51,505    $      22,331 
  Accounts payable                         287,759          252,548 
  Accrued expenses                         358,260          467,575 
  Income taxes payable                      18,012           53,915 
  Current portion of long-term debt        179,247          181,621 
_______________________________________________________________________ 

TOTAL CURRENT LIABILITIES                  894,783          977,990 
_______________________________________________________________________

LONG-TERM DEBT, NET                        487,030          523,807 

COMMITMENTS AND CONTINGENCIES 

STOCKHOLDERS' EQUITY:
  Common stock, $.01 par value,
    50,000,000 shares authorized;
    9,458,918 and 9,428,530 shares
    issued and outstanding at March 
    31, 1996 and December 31, 1995 
    (less 1,492,779 shares held in 
    treasury), respectively                 94,589           94,286 
  Additional paid-in capital             9,553,712        9,547,906 
  Accumulated deficit                   (3,513,199)      (3,813,162)
  Cumulative foreign currency
    translation adjustment                 102,653          104,914 
_______________________________________________________________________

TOTAL STOCKHOLDERS' EQUITY               6,237,755        5,933,944 
_______________________________________________________________________

TOTAL LIABILITIES AND STOCKHOLDERS'
  EQUITY                              $  7,619,568    $   7,435,741 
_______________________________________________________________________
</TABLE>

See accompanying notes to consolidated financial statements.




                                      4
<PAGE>
<TABLE>
                         BIOPOOL INTERNATIONAL, INC.

                      CONSOLIDATED STATEMENTS OF INCOME
                                 (Unaudited)
<CAPTION>
                                        Three months ending March 31,
                                            1996            1995    
_______________________________________________________________________
<S>                                   <C>             <C>
SALES                                 $  1,777,885    $   1,542,057 
_______________________________________________________________________

COSTS AND EXPENSES
  Cost of sales                            902,695          741,917 
  Selling, general and 
    administrative                         527,626          557,972 
  Research and development                  58,301           68,210 
_______________________________________________________________________

TOTAL COSTS AND EXPENSES                 1,488,622        1,368,099 
_______________________________________________________________________

OPERATING INCOME                           289,263          173,958 
_______________________________________________________________________

OTHER INCOME (EXPENSE)
  Interest income                           16,865           20,312 
  Interest expense                         (18,959)          (7,768)
  Loss on disposal of assets                    --           (1,345)
  Other                                      2,058            3,819 
_______________________________________________________________________

TOTAL OTHER INCOME (EXPENSE)                   (36)          15,018 
_______________________________________________________________________

INCOME BEFORE TAXES                        289,227          188,976 
INCOME TAXES                               (10,736)          35,131 
_______________________________________________________________________

NET INCOME                           $     299,963    $     153,845 
_______________________________________________________________________

NET INCOME PER SHARE                 $        0.04    $        0.02 
_______________________________________________________________________
</TABLE>

See accompanying notes to consolidated financial statements.







                                      5
<PAGE>
<TABLE>
                            BIOPOOL INTERNATIONAL, INC.

                       CONSOLIDATED STATEMENTS OF CASH FLOWS
                                    (Unaudited)
<CAPTION>
                                              Three months ending March 31,
                                                   1996            1995   
___________________________________________________________________________
<S>                                           <C>             <C>
CASH FLOWS FROM OPERATING ACTIVITIES          
  Net Income                                  $   299,963     $   153,845 
  Adjustments to reconcile net income to 
    net cash provided by operating
    activities:
    Depreciation and amortization                 118,261          86,958 
    Loss on disposal of assets                         --           1,346 
    Forgiveness of Biopool Sweden debt             (2,582)             -- 
    Compensation paid in stock                      2,309              -- 
  Changes in operating assets and liabilities:
    Accounts receivable                          (207,094)        (16,404)
    Inventories                                   (45,265)        (83,001)
    Prepaid expenses and other assets              14,676         (89,364)
    Refundable income taxes                        30,428              -- 
    Accounts payable                               35,211          51,734 
    Accrued expenses                             (109,315)        (19,317)
    Income taxes payable                          (35,903)        (35,216)
    Amount due to officer                              --         (10,634)
  Deferred taxes                                  (29,838)             -- 
___________________________________________________________________________
CASH PROVIDED BY OPERATING ACTIVITIES              70,851          39,947 
___________________________________________________________________________
CASH FLOWS FROM INVESTING ACTIVITIES
  Additions to property and equipment            (110,224)        (78,199)
  Proceeds from disposal of assets                     --             700 
  Patents and other assets                         47,013          (3,202)
___________________________________________________________________________
CASH USED IN INVESTING ACTIVITIES                 (63,211)        (80,701)
___________________________________________________________________________
CASH FLOWS FROM FINANCING ACTIVITIES
  Short-term borrowings                            29,174              -- 
  Repayment of long-term debt                     (42,309)        (16,974)
  Issuance of long-term debt                        5,740              -- 
  Issuance of common stock                          3,800 
___________________________________________________________________________ 
CASH USED IN FINANCING ACTIVITIES                  (3,595)        (16,974)
Effect of exchange rates                           (2,261)          4,443 
___________________________________________________________________________ 
NET INCREASE (DECREASE) IN CASH                     1,784         (53,285)
CASH AND CASH EQUIVALENTS, BEGINNING OF
  PERIOD                                        1,282,527       1,841,475 
___________________________________________________________________________ 
CASH AND CASH EQUIVALENTS, END OF PERIOD      $ 1,284,311     $ 1,788,190 
___________________________________________________________________________ 
</TABLE>
                                         6
<PAGE>
              NOTES TO CONSOLIDATED FINANCIAL STATEMENTS  (UNAUDITED)

1.   BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for
interim financial information and with the instructions to Form 10-QSB and
Article 10 of Regulation S-X.  Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting
principles for complete financial statements.  In the opinion of
management, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included.  Operating
results for the three month period ended March 31, 1996 is not necessarily
indicative of the results that may be expected for the year ended December
31, 1996.  For further information, refer to the consolidated financial
statements and footnotes thereto included in the Company's annual report on
Form 10-K for the year ended December 31, 1995.

The balance sheet at December 31, 1995 has been derived from the audited
financial statements at that date but does not include all of the
information and footnotes required by generally accepted accounting
principles for complete financial statements.

2.   INVENTORIES
<TABLE>
Inventories consist of the following:
<CAPTION>
                                        March 31,      December 31,
                                          1996            1995    
  <S>                                 <C>              <C>
  Raw materials                       $   632,087      $  616,637 
  Work in process                         725,047         706,520 
  Finished products                       530,041         518,753 
                                      ____________     ___________

                                      $ 1,887,175      $1,841,910 
                                      ____________     ___________
</TABLE>
3.   INCOME TAXES

The Company accounts for income taxes under Statement of Financial
Accounting Standards No. 109 ("SFAS 109"), "Accounting for Income Taxes." 
Income taxes are provided based on earnings reported for financial
statement purposes.  Deferred taxes are provided on the temporary
differences between income for financial statement and tax purposes.

In accordance with the provisions of SFAS 109, the Company regularly
evaluates the components of its temporary differences and the related
allowance account.  At March 31, 1996, the Company reduced its allowance
account approximately $100,000 in order to properly reflect the future
benefit of such differences.




                                         7

<PAGE>
4.   NET INCOME PER SHARE

The net income per common share is based on the average number of common
shares outstanding during each year (1996 - 7,949,343, 1995 - 7,893,366). 
The exercise of outstanding options would have an immaterial effect on
earnings per share.

















































                                         8

<PAGE>
             MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION


FINANCIAL CONDITION

At March 31, 1996, the Company had cash and cash equivalents of
approximately $1,284,000 and unused lines of credit of approximately
$670,000.  Working capital has remained strong at approximately 5.5 to 1.0. 
With the recent introduction of new products and the elimination of non-
recurring professional fees associated with the settlement of litigation in
late 1995, management believes that the Company will continue to strengthen
its financial condition.

Cash flows from operating activities were $70,851 for the three months
ended March 31, 1996, an increase of approximately $30,904, or 77%, over
the same period in 1995.  This increase was primarily due to higher sales
volume and a reduction in non-recurring professional fees.

The Company believes that its current capital resources, including existing
cash and access to available lines of credit, together with funds generated
from operations, should be sufficient to meet the Company's operating
requirements through the remainder of 1996.  The Company may use a portion
of its cash to acquire businesses, products, or technologies complementary
to its business, although it has no such commitments and no such
acquisitions are currently being negotiated or planned.

RESULTS OF OPERATIONS

Sales increased by $235,828, or 15%, to $1,777,885 for the period ended
March 31, 1996, compared to the corresponding period in 1995.  Sales
increased generally throughout all product areas, including significant
growth in Minutex-R- D-Dimer, as well as enhanced sales to certain key OEM
accounts.  Management expects to see continued growth in these areas during
the remainder of 1996.

During the period ended March 31, 1996, one customer accounted for 15% of
sales.

Cost of sales, as a percent of sales, increased approximately by 3%, from
48% to 51%, for the period ended March 31, 1996, compared to the
corresponding period in 1995.  This increase was due primarily to the
product mix sold during the period and does not, in the opinion of
management, reflect a significant trend toward higher cost of sales.

Selling, general and administrative expenses, decreased approximately
$30,346, or 5%, over the corresponding period in 1995.  This was due to a
reduction in non-recurring professional fees and personnel costs partially
offset by increased depreciation expenses associated with capital and
leasehold equipment purchases.

Net income increased 95% to $299,963 in the first quarter of 1996 from
$153,845 in the same period in 1995.  This was largely due to continuing
growth in private-label accounts and the introduction of new products.


                                         9

<PAGE>
                                      PART II



ITEM 1.  LEGAL PROCEEDINGS

   In December 1995, the Company settled a lawsuit with another company. 
Under the terms of the settlement, the Company will pay royalties on
certain products sold after December 20, 1995.  In addition, the Company
agreed to pay the sum of $100,000, the total of which was paid by its
insurance company.












































                                        10

<PAGE>
                                    SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





Date:   April 29, 1996                BIOPOOL INTERNATIONAL, INC.
        ______________                ___________________________
                                      (Registrant)





                                      /s/ Michael D. Bick, Ph.D.
                                      ___________________________

                                      Michael D. Bick, Ph.D.
                                      Chief Executive Officer and
                                      Chairman of the Board





                                      /s/ Jeffrey C. Hass
                                      ___________________________

                                      Jeffrey C. Hass
                                      Secretary and Director of Finance




















                                        11

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                       1,284,311
<SECURITIES>                                         0
<RECEIVABLES>                                1,373,558
<ALLOWANCES>                                    12,856
<INVENTORY>                                  1,887,175
<CURRENT-ASSETS>                             4,958,622
<PP&E>                                       3,595,254
<DEPRECIATION>                               1,808,372
<TOTAL-ASSETS>                               7,619,568
<CURRENT-LIABILITIES>                          894,783
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        94,589
<OTHER-SE>                                   9,656,365
<TOTAL-LIABILITY-AND-EQUITY>                 6,237,755
<SALES>                                      1,777,885
<TOTAL-REVENUES>                             1,777,885
<CGS>                                          902,695
<TOTAL-COSTS>                                1,488,622
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,959
<INCOME-PRETAX>                                289,227
<INCOME-TAX>                                  (10,736)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   299,963
<EPS-PRIMARY>                                      .04
<EPS-DILUTED>                                      .04
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission